
|Articles|October 26, 2016
Associations Urge CMS to Abandon Reimbursement Cuts for Low-Dose CT Scans
Author(s)Bobby Lazzara, MD
This Medical News Minute outlines efforts by a number of advocacy groups and medical associations urging the CMS to abandon proposed reimbursement cuts to low-dose CT screening for lung cancer.
Advertisement
In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses efforts by a number of advocacy groups, health care systems, and medical associations urging the Centers for Medicare & Medicaid Services (CMS) to abandon proposed reimbursement cuts to low-dose CT screening for lung cancer.
The changes to reimbursement are laid out in the 2017 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
2
The Lowest-Ever Hazard Ratio in Multiple Myeloma Bispecific Trials?
3
Developers Initiate Phase 2/3 Ivonescimab/EV Trial in Bladder Cancer
4
Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma
5





















































